819 Capital Partners
Overview
819 Capital Partners is a dynamic investment firm specializing in venture capital, private equity, and corporate finance. The firm operates from offices in Deventer and Amsterdam, focusing on sectors such as healthcare, technology, and leisure. Their mission is to drive innovation, growth, and value creation for partners through a diverse portfolio of investments. The firm launched the 819 Evergreen Fund I in October 2023, an open-ended fund focusing on deep tech addressing societal challenges in multiple sectors, including healthcare and technology. This fund invests in start-ups and scale-ups, primarily focusing on minority interests, with a long-term perspective to achieve sustainable value creation. In October 2025, 819 Capital Partners launched the 819 Seed Fund, a €9 million fund designed to meet the growing demand for venture capital among early-stage deep tech and med tech companies, offering ticket sizes from €250k to €1.5M. 819 Capital Partners has a track record of strategic investments, including a significant minority stake in RiverD International in January 2026, a Dutch high-tech company developing advanced instruments for non-invasive molecular analysis of human skin and tissue using Raman spectroscopy. The firm also acquired and invested in CiMaas, a biotech company specializing in Natural Killer cell therapy for cancer treatment, in November 2024. These investments reflect the firm's commitment to supporting innovative companies with high growth potential in key sectors.
Investment Focus
- Deep-tech companies addressing societal challenges in healthcare and technology sectors
- Exceptional leadership teams
- Promising and distinctive market positions
- Compliance with ESG and/or SDG criteria
Portfolio Companies
Reach 819 Capital Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about 819 Capital Partners
What sectors does 819 Capital Partners invest in?
819 Capital Partners invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Amsterdam, Netherlands. 819 Capital Partners is listed as a private equity in the ConnectSafely investor database.
What stage does 819 Capital Partners invest at?
819 Capital Partners backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 250K - 1.5M.
Which regions does 819 Capital Partners invest in?
819 Capital Partners invests across Netherlands.
Who are the partners at 819 Capital Partners?
Team members listed for 819 Capital Partners include Thomas Smit (Partner and co-founder) and Sven Kempers (Partner and co-founder).
What companies has 819 Capital Partners invested in?
819 Capital Partners's portfolio includes Carbyon, ANTENNEX, Mesh ID, Neuroplast, CiMaas, RiverD International, Direct Diagnostics and Fox Reizen.
How do I contact 819 Capital Partners?
819 Capital Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
